This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
Mus musculus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
B cell (Raji)
Blood
Bone marrow-derived mesenchymal stem cell (R14)
Breast cancer cell (MCF7)
Breast cancer cells (4T1)
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Colon cancer cell (HCT116)
Colon cancer cell (HT29)
Colon cancer cell (RKO)
Colon cancer cell (SW48)
Colon cancer cell (SW480)
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Drug-resistant breast adenocarcinoma cell (MCF-7 MDR variant MCF-7/DX)
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Lung cancer cell (SBC-3)
Lung cancer cells (A549)
Malignant melanoma cell (A375)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Mast cell (HMC-1)
Metastatic gastric cancer cell (AZ521)
Oral cancer cells (HOC313-LM)
Oral cancer cells (HOC313-P)
Plasma
Primary dendritic cell
Saliva
Serum
T cell (Jurkat)
By sample status
24 hr culture
72 hr culture
Cisplatin-resistant
Extremely severe hand, foot, and mouth disease
Healthy_timepoint1
Healthy_timepoint2
High density
Mild hand, foot, and mouth disease
Normal
Normal_Agilent
Normal_Exiqon
Oral lichen planus patient
Pancreatic cancer patient_Agilent
Pollen allergy_timepoint1
Pollen allergy_timepoint2
Transplant islets into mouse xenotransplantation-rejected
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
ppy-miR-575
MIMAT0016016
0.0e+0
3.3e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
0.0e+0
3.7e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000586_1
46
/
0
/
46
ppy-miR-575
MIMAT0016016
0.0e+0
3.8e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000586_1
46
/
0
/
46
ptr-miR-575
MIMAT0008249
0.0e+0
4.5e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000586_1
46
/
0
/
46
ptr-miR-575
MIMAT0008249
0.0e+0
8.6e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000586_1
46
/
0
/
46
ppy-miR-575
MIMAT0016016
0.0e+0
7.1e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000586_1
46
/
0
/
46
ptr-miR-575
MIMAT0008249
0.0e+0
1.7e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
0.0e+0
1.7e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000586_1
46
/
0
/
46
ptr-miR-575
MIMAT0008249
0.0e+0
4.9e-4
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
0.0e+0
3.5e-1
Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients.
Oral Dis. 2015 Sep 21. doi: 10.1111/odi.12374.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
0.0e+0
1.6e-11
Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing.
RNA Biol. 2016 Oct 28:0.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
0.0e+0
6.8e-2
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
0.0e+0
8.0e-2
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
0.0e+0
3.9e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
0.0e+0
3.8e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
0.0e+0
3.2e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
0.0e+0
3.1e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
0.0e+0
8.7e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
0.0e+0
6.7e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
1.7e-3
1.7e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000586_1
46
/
0
/
46
hsa-miR-575
MIMAT0003240
3.6e-4
3.6e-4
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000586_1
46
/
0
/
46
<
[3]